Respiratory panel multiplex PCR

Alphabetical Test listing

Respiratory panel multiplex PCR-12653

  
Respiratory panel multiplex PCR
  
12653
  
LAB12653
  
RESP
  
Respiratory panel;Respiratory viral panel;RPP;RVP;Viral;Viral panel
  
  • Adenovirus (AdV)
  • Coronavirus (CoV) 229E, HKU1, NL63, OC43
  • Enterovirus (EV)
  • Human Rhinovirus (HRV)
  • Human Metapneumovirus (hMPV)
  • Influenza A (Flu A) (subtypes H1, H1-2009, and H3)
  • Influenza B (Flu B)
  • Parainfluenza Virus 1 (PIV1)
  • Parainfluenza Virus 2 (PIV2)
  • Parainfluenza Virus 3 (PIV3)
  • Parainfluenza Virus 4 (PIV4)
  • Respiratory syncytial virus (RSV)
  • Bordetella pertussis
  • Chlamydophila pneumonia
  • Mycoplasma pneumoniae

 

  

Triage of in-patients, emergency department/observation patients, and high-risk outpatients (immunocompromised or underlying cardiac/lung conditions) presenting with signs and symptoms of acute respiratory illness. Tests for 17 viral and 3 bacterial respiratory pathogens, however, does NOT detect COVID-19 (2019 Novel) Coronavirus, MERS (Middle Eastern Respiratory Syndrome) or SARS (Severe Acute Respiratory Syndrome).

The Respiratory panel multiplex PCR is restricted to selected inpatients at Allina facilities only.  

The Allina Infectious Disease Task Force has determined that this panel is NOT appropriate for ambulatory patients unless ordered by an Allina infectious disease physician.  

Ambulatory patients should have targeted testing for respiratory pathogens if indicated.

  
Flocked nasopharyngeal (NP) swab
  
  

BD Universal Viral transport media (UTM)

 

  

Viral transport media (VTM), M4, M4RT or M5

Buffered saline (PBS)

  

Viral transport media (VTM), M4, M4RT or M5

Buffered saline (PBS)

 

  

Refrigerated (preferred) - 3 days

Ambient - 4 hours

Frozen (<-15°C) - 30 days

  

This assay does not detect COVID-19 (2019 Novel) Coronavirus, MERS (Middle Eastern Respiratory Syndrome) or SARS (Severe Acute Respiratory Syndrome).

  
AHL - Microbiology: M
  
Daily
  
2.5 hours after receipt at the Allina Health Central Laboratory
  

Real time Polymerase Chain Reaction (RT-PCR)

  

Not detected

  

Detected:  The assay(s) for the organism were POSITIVE.

Not detected:  The assay(s) for the organism were NEGATIVE.

Invalid:  Failure of assay controls.  Unable to determine detected (positive) or not detected (negative) for the target organism(s).

The results of this test should not be used as the sole basis for diagnosis, treatment, or other management decisions.

Organism (abbreviation)

Classification

(Genome type)

Season of Highest

Incidencea

Most Commonly Infected

Demographic

Adenovirus (AdV)

Adenovirus (DNA)

Late winter to early

summer

All ages,

immunocompromised

Coronavirus (CoV) 229E,HKU1, NL63, OC43

Coronavirus (RNA)

Winter, spring

Children, adults

Enterovirus (EV)

Picornavirus(RNA)

Summer, early fall

All ages

Human Rhinovirus (HRV)

Picornavirus (RNA)

Fall, spring

All ages

Human Metapneumovirus

(hMPV)

Paramyxovirus (RNA)

Winter, early spring

Children

Influenza A (Flu A)

(subtypes H1, H1-2009, and H3)

Orthomyxovirus (RNA)

 

Winter

All ages, 5-20 % of US

populationb

Influenza B (Flu B)

Orthomyxovirus (RNA)

Winter

All ages, 5-20 % of US

Populationb

Parainfluenza Virus 1 (PIV1)

Paramyxovirus (RNA)

Fall, periodicity of 1-2

years

Infants, young children,

immunocompromised

Parainfluenza Virus 2 (PIV2)

Paramyxovirus (RNA)

Fall, periodicity of 1-2

years

Infants, young children,

immunocompromised

Parainfluenza Virus 3 (PIV3)

Paramyxovirus (RNA)

Spring, summer

Infants, young children,

Immunocompromised

Parainfluenza Virus 4 (PIV4)

      Paramyxovirus (RNA)

Unknown

All ages

Respiratory Syncytial Virus

(RSV)

Paramyxovirus (RNA)

Winter, varies by

location[

Children, older adults

 

Bordetella pertussis

Bacterium (DNA)

No peak season

All ages

Chlamydophila pneumoniae

Bacterium (DNA)

No peak season

Older children, young adults,

immunocompromised

Mycoplasma pneumoniae

Bacterium (DNA)

Outbreaks most common

in summer, outbreak

periodicity 4 – 7 years

Older children, young adults

a Based on North American seasons

b During annual Influenza epidemics, 5-20% of the population is affected with upper respiratory tract infections with rapid onset of fever.

  
0099U
  
No
  
10/08/2015
  
12/17/2020
  
03/03/2020